S01 E06
Surgbots Podcast

The Role of Acquisitions in Surgical Robotics

The Surgical Robotics industry is a rapidly developing space. On Episode 6 of The Surgibots Podcast I sat down with the President and CEO at eCential Robotics, Stéphane Lavallée, to discuss the importance of partnerships and acquisitions in our industry.

The Role of Acquisitions in Surgical Robotics

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
Surgibots Ep 6

The Role of Acquisitions in Surgical Robotics

What did you learn from previous acquisitions? 

 Listen to the companies that can potentially acquire your startup. It's very important to have information on what their vision is, where they want to go, what you need to target, etc. Big companies will usually make acquisitions because they have long term plans, so you need to focus on something which is in their vision, not not totally outside their scope. The more information you can have on their partnerships, the better your relationship will be.  

Focus. You have to be very careful when establishing a startup to do one thing. If you’re only doing one thing you need to be the best in the world at doing it. I see startups saying ‘We are going to create a global solution from scratch’. If you want to be acquired, that’s not a reasonable goal.  

 Build partnerships with key opinion leaders. Surgeons have a big voice, so you have to listen to them very carefully. Their recommendations, including on your technology, will really matter. They have a clear vision of the surgical implications and clinical issues. Have a good discussion about ‘Do you like this technology? Do you prefer that technology?’ It’s really important to create a product that’s based on clinical needs, inspired by the key opinion leaders.  

What lessons could you share with other entrepreneurs?  

 Never give up. It happens so often in the life of a startup -  things get hard and you are discouraged. Things don’t work. You might have a problem with the technology, the competition or the IP. You might have no money so you cannot pay the salaries at the end of the month. Sometimes you're really in a hole. There is always a moment where you are discouraged and you want to stop. This is where you need to resist all those pressures and stay alive. It's a question of finding solutions. Don't let the company die, don't give up. It's impossible to have a 100% success rate. Whether you change something significant, you restructure, whatever it is, just continue. It’s that simple. 

To learn more about start-up acquisitions in the surgical robotics space, tune into Episode 6 of The Surgibots Podcast here.  

 

 

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge
Podcast43

What's the Hype with Neuro? A Lesson in the Brain - With Hannah Claridge

In this episode, your host, Henry Norton, is joined by Hannah Claridge, the Head of Neurotechnology at TTP, to talk about the incredible advancements that are being made to treat neurological conditions. Hannah points out how complex the brain and nervous systems are, with both relying on intricate connections. She also explores the new technologies that are being developed to treat nervous disorders, such as spinal cord stimulation. She also compared neurotechnologies to pharmaceuticals, highlighting the parallels and differences in how they interact with the body. Hannah also suggested that neurotherapy will be key to the advancement of treatments for conditions like depression, due to their ability to provide targeted and long-term relief of symptoms. Cybersecurity is also a major concern for neurotechnology, as any malfunction or deliberate interference could have serious ramifications for patients.
Why Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUS
Podcast42

Why Most Medtech Fundraisers Fail and What to Do Instead - Kiko Filipov, Partner at APPARIUS

Raising capital in Medtech is tougher than ever. Investor expectations have shifted. Competition is up. And many founders are still pitching like it’s 2018. In this episode, Henry Norton sits down with Kiko Filipov, Partner at APPARIUS Corporate Finance and Strategic Advisor at Cruxx, to unpack the real mechanics of a successful fundraise in 2025. From first-in-human data to commercial readiness, Kiko shares what separates the rounds that get oversubscribed from the ones that stall. He also explores the changing landscape of Medtech innovation and why strategic exits take years of planning, how emerging markets are joining the race, and where VCs are placing bets across surgical robotics, neurostimulation, and digital health. Whether you're gearing up for Series A or preparing your pitch deck, this episode delivers tactical clarity from someone who’s in the room with both founders and funds.

Discover more about Medical Devices